Today: 9 June 2026
Browse Category

NYSE:HUM 5 November 2025 - 29 January 2026

Dow Jones flattens near 49,000 as S&P 500 hits 7,000; Fed and Big Tech earnings loom

Dow Jones flattens near 49,000 as S&P 500 hits 7,000; Fed and Big Tech earnings loom

The Dow rose 49.62 points to 49,053.03 by midday Wednesday as the S&P 500 briefly topped 7,000 before retreating. Intel jumped 11.3%, while UnitedHealth plunged nearly 20% after the Trump administration proposed a 0.09% Medicare Advantage rate hike for 2027. The Fed is expected to hold rates steady. Seagate surged 19.3% on earnings.
28 January 2026
·······
Dow Jones today: Dow hovers near 49,000 as Fed decision and mega-cap earnings loom

Dow Jones today: Dow hovers near 49,000 as Fed decision and mega-cap earnings loom

The Dow Jones hovered near 49,000 Wednesday morning, dipping 3.56 points to 48,999.85 as UnitedHealth’s sharp fall continued to weigh on the index. The S&P 500 briefly topped 7,000, boosted by chip stocks after upbeat results from ASML and SK Hynix. The Federal Reserve’s policy decision is due at 2 p.m. EST. Meta, Microsoft, Tesla, and IBM report earnings after the bell.
28 January 2026
···········
Dow Jones today: Dow futures inch up as Fed decision and Big Tech earnings loom

Dow Jones today: Dow futures inch up as Fed decision and Big Tech earnings loom

Dow futures rose about 30 points ahead of the Fed’s policy decision, with S&P 500 and Nasdaq 100 futures also up. Health insurers slumped after U.S. officials proposed a 0.09% Medicare Advantage payment hike, far below expectations. The Dow fell 409 points Tuesday, dragged by UnitedHealth, Humana, and CVS losses, while the S&P 500 and Nasdaq hit records on tech gains. Microsoft and Meta will report earnings Wednesday.
28 January 2026
·····
Humana stock price tumbles 21% after Medicare Advantage rate proposal — what to watch next

Humana stock price tumbles 21% after Medicare Advantage rate proposal — what to watch next

Humana shares fell 21.1% to $207.93 in after-hours trading Tuesday after the Centers for Medicare & Medicaid Services proposed a 0.09% average payment increase for Medicare Advantage in 2027, far below analyst expectations. The draft also included stricter rules on diagnosis data. U.S. health insurer stocks dropped sharply, erasing billions in market value. Comments on the proposal are due by Feb. 25.
28 January 2026
··
UnitedHealth Group stock price tumbles: UNH slides nearly 20% after outlook, Medicare Advantage rates in focus

UnitedHealth Group stock price tumbles: UNH slides nearly 20% after outlook, Medicare Advantage rates in focus

UnitedHealth Group shares fell 19.5% to $282.90 in after-hours trading Tuesday after a weak Medicare Advantage rate proposal from the Trump administration. The company expects to lose up to 1.4 million Medicare Advantage members in 2026 and forecasts a drop in Medicaid membership. CVS and Humana shares also plunged. The government’s final Medicare Advantage rate decision is due April 6.
27 January 2026
···
UnitedHealth stock tumbles nearly 20% as Medicare Advantage rate proposal rattles UNH investors

UnitedHealth stock tumbles nearly 20% as Medicare Advantage rate proposal rattles UNH investors

UnitedHealth shares fell 18.4% to $286.96 Tuesday after a U.S. proposal signaled Medicare Advantage payments would rise just 0.09% in 2027. The company warned of its first revenue drop since 1989 despite maintaining its 2026 profit outlook. CVS Health and Humana also posted sharp declines. CMS will accept comments on the proposed rates through Feb. 25.
27 January 2026
···
Dow Jones drops 450 points as UnitedHealth sinks on Medicare rates; confidence slumps

Dow Jones drops 450 points as UnitedHealth sinks on Medicare rates; confidence slumps

The Dow Jones fell 445 points, or 0.9%, to 48,966 in early trading, dragged down by a 20% plunge in UnitedHealth after weak Medicare payment proposals and a downbeat 2026 forecast. U.S. consumer confidence dropped to its lowest since 2014. The S&P 500 and Nasdaq rose, while Humana and CVS also tumbled. Traders watched for earnings and the Fed meeting starting Tuesday.
27 January 2026
···
Why UnitedHealth stock fell today: UNH slides as Medicare Advantage spotlight returns

Why UnitedHealth stock fell today: UNH slides as Medicare Advantage spotlight returns

UnitedHealth shares fell 2.3% to $331.02 in after-hours trading Friday following a MedPAC report highlighting $76 billion in projected Medicare Advantage overpayments. The drop came ahead of a long holiday weekend and the company’s earnings release set for Jan. 27. Managed-care stocks broadly declined, with Humana down 3.76% and Elevance Health off 1.85%.
17 January 2026
···
UnitedHealth stock drops today — what traders are watching before UNH earnings

UnitedHealth stock drops today — what traders are watching before UNH earnings

UnitedHealth shares fell 1.3% to $334.40 Friday, weighing on the Dow as managed-care stocks slid after Trump’s new healthcare proposal. The plan, which would replace insurance subsidies with direct payments to consumers, left policy details unclear and insurers under pressure. UnitedHealth will report 2025 earnings and its 2026 outlook on Jan. 27. Investors are watching for updates on government-plan costs and future guidance.
16 January 2026
······
UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

UnitedHealth shares fell over 2% to $340.44 Wednesday morning, erasing part of Tuesday’s gain. The drop followed analyst moves, with Bernstein raising its target to $444 and Evercore ISI starting coverage at $400. Investors await UnitedHealth’s Jan. 27 results and Medicare Advantage rate updates. Humana and Cigna also declined.
7 January 2026
·······
UnitedHealth stock ticks up after Barclays target hike as UNH earnings near

UnitedHealth stock ticks up after Barclays target hike as UNH earnings near

UnitedHealth shares rose 0.8% to $338.94 in late-morning trading Monday after Barclays raised its price target to $391 and reiterated an Overweight rating. Investors are watching ahead of Jan. 27, when UnitedHealth will report 2025 results and 2026 guidance. Scrutiny remains on medical-cost trends, operational review progress, and ongoing Justice Department investigations into Medicare Advantage billing.
5 January 2026
·····
UnitedHealth stock rises into the weekend — what UNH investors watch before Jan. 27 results

UnitedHealth stock rises into the weekend — what UNH investors watch before Jan. 27 results

UnitedHealth Group shares rose 1.9% to $336.40 Friday, trading 6.9 million shares and closing above key moving averages. The company will report full-year results and its 2026 outlook before the market opens Jan. 27. UnitedHealth remains under Justice Department investigation over billing practices. The stock is well below its 52-week high of $606.36.
5 January 2026
····
UnitedHealth Group (UNH) Stock After Hours Today (Dec. 15, 2025): Key News, Analyst Forecasts, and What to Watch Before Tuesday’s Open

UnitedHealth Group (UNH) Stock After Hours Today (Dec. 15, 2025): Key News, Analyst Forecasts, and What to Watch Before Tuesday’s Open

UnitedHealth (UNH) closed Monday down 0.22% at $341.10 and slipped to $340.14 after hours. The move followed Fitch’s downgrade of rival Humana, citing higher medical costs and weaker Medicare Advantage bonuses. UNH traded 6.3 million shares in a $337–$344.96 range. Industry commentary remains focused on rising expenses and regulatory pressure.
16 December 2025
···
Humana Stock (HUM) Outlook December 4, 2025: Earnings Beat, Legal Risks and 2026 Medicare Advantage Forecast

Humana Stock (HUM) Outlook December 4, 2025: Earnings Beat, Legal Risks and 2026 Medicare Advantage Forecast

Humana shares traded in the mid-$250s on December 4, down 12% over the past year and 18% below their September high. The stock is up just 1.3% year to date, lagging the SPDR S&P Health Care Services ETF’s nearly 20% gain. Institutional investors, including Norges Bank, increased stakes in 2025, with about 92% of shares now institutionally held. Regulatory headlines and guidance changes have driven sharp price swings.
4 December 2025
··
Humana (HUM) Stock on Nov 5, 2025: Earnings Beat, Outlook Trimmed – Full Analysis

Humana (HUM) Stock on Nov 5, 2025: Earnings Beat, Outlook Trimmed – Full Analysis

Humana shares traded at $269 on Nov 5, 2025, after Q3 earnings beat expectations with adjusted EPS of $3.24 and revenue of $32.65 billion. The company reaffirmed full-year adjusted EPS guidance but cut its GAAP forecast due to higher medical costs. Shares fell 4% pre-market. Humana projects a 7% drop in Medicare Advantage membership for 2025 after a major plan’s star rating downgrade.
5 November 2025
··
1 2 3

Stock Market Today

  • Coupang (CPNG) Shares Drop Amid Growth Investment; Valuation Seen Undervalued at $27.24
    June 9, 2026, 5:12 PM EDT. Coupang's stock declined over 11% in the past month and 35% year-to-date, pressured by ongoing net losses and aggressive investments. The South Korean e-commerce firm reported $35.13 billion in annual revenue but a $165 million net loss, driven by expansions in Product Commerce and Developing Offerings like delivery and fintech. At $15.18 per share, it's trading well below analysts' $27.24 fair value estimate, suggesting a 44% undervaluation. Improved operational efficiencies from automation and AI investments bolster long-term margin and earnings growth prospects. However, regulatory risks post-2025 data breach and losses in new markets like Taiwan pose challenges. Investors weigh Coupang's growth potential against near-term financial headwinds amid a volatile stock performance period.

Latest articles

RBC Stock Hits 52-Week High Even as TSX Falls

RBC Stock Hits 52-Week High Even as TSX Falls

9 June 2026
Royal Bank of Canada surged to a new 52-week high at C$277.09 before closing up 1.24% at C$276.01, outpacing the S&P/TSX’s 0.2% drop, after reporting Q2 net income of C$5.5 billion and adjusted EPS of C$3.90, beating estimates. Despite strong results and a 58.61% year-over-year gain, risks remain as the market is not cheap and investors await the Bank of Canada’s rate decision.
BigBear.ai Stock Drops as Panama AI Buzz Runs Into Dilution Worries

BigBear.ai Stock Drops as Panama AI Buzz Runs Into Dilution Worries

9 June 2026
BigBear.ai shares fell 33 cents to $3.98 as investors weighed a Panama cargo-security deployment, annual meeting results, and the company’s ongoing losses; despite a 14% backlog jump and $431.5 million in cash, revenue conversion remains uncertain, and a recent increase in authorized shares raises dilution risks.
Velo3D shares jump on gas-turbine order; VELO gains traction

Velo3D shares jump on gas-turbine order; VELO gains traction

9 June 2026
Velo3D shares soared 21% to $19.64 after announcing a gas-turbine manufacturing partnership with Aurelia Technologies using its Sapphire XC platform, expanding beyond aerospace and defense; no order value disclosed, so gains reflect expected future work as investors await Wednesday’s investor presentation.
Colorado PERA pay dispute spotlights mix of big bonuses and lower pensions

Colorado PERA pay dispute spotlights mix of big bonuses and lower pensions

9 June 2026
Colorado’s public pension fund paid $11.7 million in bonuses to investment staff after losing $9.8 billion in 2022, even as retirees’ checks lag inflation and the fund faces a $29 billion gap, fueling scrutiny over rising compensation while retirees and taxpayers absorb cuts and higher contributions.
Wall Street on Edge as Nasdaq AI Losses Deepen Before CPI, IPOs

Wall Street on Edge as Nasdaq AI Losses Deepen Before CPI, IPOs

9 June 2026
Nasdaq plunged 1.21% and S&P 500 fell 0.53% as tech and AI stocks resumed their sharp selloff, with the S&P tech index down over 4% at one point, while investors braced for Wednesday’s key CPI inflation data, Iran risks, and a wave of major IPOs that could force further stock rotation.
Go toTop